SIPAI HEALTH(00314): Strategic acquisition of Jianyi Technology to elevate the "commercial insurance + enterprise health" ecosystem, with the potential for faster profit growth.

On March 18, SIPAI HEALTH (00314) announced that it will acquire 100% equity of Jianyi Information Technology (Shanghai) Co., Ltd. ("Jianyi Technology") through its wholly-owned subsidiary for a total price of 360 million yuan. Jianyi Technology is positioned as a leading commercial medical insurance technology and corporate employee healthcare service platform in China, holding national high-tech enterprise qualifications. It mainly provides integrated "technology + service" solutions for insurance companies and large and medium-sized enterprises. For SIPAI HEALTH, this strategic acquisition is not only an important addition to its commercial insurance business, but also a crucial piece to complete its "insurance, health management, medical care, pharmaceuticals" one-stop closed-loop ecosystem. In the year of 2026 when the policy dividends for commercial insurance continue to be released, this integration is expected to accelerate the company's profit process and inject new growth momentum for the company's future development. The deep integration of commercial insurance, medical care, and pharmaceuticals, accelerates the perfection of the Sipai enterprise healthcare service ecosystem. In recent years, with changes in population structure and the continuous upgrading of medical needs, the commercial health insurance market has steadily expanded. According to data from the China Banking and Insurance Regulatory Commission, the original premium income of commercial health insurance in China reached 997.3 billion yuan by 2025, approaching the trillion yuan mark; with an average annual compound growth rate of over 20% in the past decade, the industry's development has entered the fast lane. In 2026, multiple favorable policies continue to be released: the "Government Work Report" mentioned "commercial health insurance" twice, not only listing the "launch of a commercial health insurance innovation drug catalog" as an important achievement for 2025, but also explicitly proposing to "accelerate the development of commercial health insurance." The Beijing "Eighteen Measures for Commercial Insurance" encourage the relaxation of insurance conditions, allowing the use of personal medical insurance account funds to purchase commercial insurance, among other supportive policies, which are expected to bring vast potential demand to the industry. Behind the expansion of the industry, the role of commercial health insurance in the medical system is quietly evolving: with the deep integration of commercial insurance with medical care, medical insurance, and pharmaceuticals, commercial insurance is gradually transforming from a simple expense reimbursement tool to a builder of the health industry's ecosystem. The approaching opportunity favors the early birds. Since 2024, SIPAI HEALTH has keenly captured the industry trend, proactively establishing a development strategy with "commercial medical insurance as the core," focusing on the medical security and health management needs of enterprise employees, and committed to creating an integrated service ecosystem of "insurance, health management, medical care, pharmaceuticals." In terms of commercial medical insurance, Sipai has accumulated a high-viscosity premium customer base. According to the latest company introduction, Sipai's commercial insurance brokerage business serves over 600 leading companies in various industries nationwide, covering more than 2 million members. As of its 2025 interim report as of June 30, the company's managed premium scale was approximately 860 million yuan, a year-on-year increase of approximately 35%, with a renewal rate of premiums reaching as high as 105.3%. In terms of medical care and pharmaceuticals, Sipai continues to integrate a national network of medical services and pharmaceutical supplies, constructing a comprehensive health management service system covering the entire process from "prevention, management, to post-assistance." As of the end of June 2025, the company had signed contracts with nearly 10,000 health check service locations, operated 65 corporate medical rooms, assumed the daily diagnosis and treatment needs of common and chronic diseases for enterprise employees, with a total of 87,000 visits in the first half of the year; contracted with 118 high-quality commercial medical institutions and more than 10,000 cooperative pharmacy locations. The acquisition of Jianyi Technology aligns closely with SIPAI HEALTH's established strategic direction. It is understood that Jianyi Technology adopts a core model of "insurance + medical health + technology," relying on its independently developed medical insurance smart cloud platform and a nationwide medical service network to digitally connect insurance companies, medical service institutions, B2B, and B2C commercial insurance users, achieving full-chain integration of insurance claims, medical delivery, and user services. In terms of resources, Jianyi Technology has extensive ecological coverage and customer outreach capabilities, serving over 200 branches of insurance companies and covering nearly 300,000 medical and pharmaceutical service institutions. After integration, it is expected to help Sipai swiftly improve market penetration and perfect its own service and resource network. In terms of technology, as a national high-tech enterprise, Jianyi Technology has its independently developed cloud health insurance platform, and its AI intelligent core claims control system has handled over 40 million claims cases. After integration, Jianyi's AI technological capabilities are expected to fully empower Sipai's service ecosystem: in advance, using data analysis to accurately identify health trends, aiding in the development of differentiated and personalized health management and insurance plans; in the middle, strengthening dynamic risk management for claims payment; and afterwards, improving claims efficiency and service responsiveness, optimizing user experience, and enhancing customer stickiness. In addition, from a market perspective, Jianyi Technology has demonstrated a stable revenue scale and healthy profit margins in the past, serving as a high-quality asset with self-generating capabilities. After the acquisition is completed, it is expected to directly boost SIPAI HEALTH's performance, helping to optimize the income structure and solidify the foundation for sustainable development. With its existing advantages in the integrated ecosystem, SIPAI HEALTH has already occupied a favorable position in the blue ocean market of enterprise health. Against the backdrop of the "policy big year" for commercial health insurance in 2026, with the accelerated integration, complementary advantages, and synergistic effects being released by the acquirer and the target company, SIPAI holds the potential to accelerate the consolidation of its competitive moat and steadily move towards a path of high-quality, sustainable growth.